Florbetaben

N/A

Report date: 2025/12/04 09:33:21

Base Information

Drug NameFlorbetaben
Drug Alias NameLNTH-2515LNTH-2515
ClassificationRadiation-emitting products > Radioactive diagnostic agent
Mechanisms of ActionTransthyretin stabilizers
TargetsAmyloidTransthyretin
Therapy Area/IndicationsTransthyretin amyloidosisImmunoglobulin Light-chain Amyloidosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesArcus Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesLantheus Holdings Inc
Inactive CompaniesN/A
Active IndicationsTransthyretin amyloidosisImmunoglobulin Light-chain Amyloidosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A